Integrin Inhibitor Suppresses Bevacizumab-Induced Glioma Invasion()()

Glioblastoma is known to secrete high levels of vascular endothelial growth factor (VEGF), and clinical studies with bevacizumab, a monoclonal antibody to VEGF, have demonstrated convincing therapeutic benefits in glioblastoma patients. However, its induction of invasive proliferation has also been...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ishida, Joji, Onishi, Manabu, Kurozumi, Kazuhiko, Ichikawa, Tomotsugu, Fujii, Kentaro, Shimazu, Yosuke, Oka, Tetsuo, Date, Isao
Formato: Artigo
Idioma:Inglês
Publicado: Neoplasia Press 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4101347/
https://ncbi.nlm.nih.gov/pubmed/24704537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2014.02.016
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares